Synthesis and antiviral assays of some 2-substituted benzimidazole-N- carbamates

Farmaco

Volumn 55, Issue 1, 2000, Pages 35-39

  Garuti, L ^a   Roberti, M ^a   Gentilomi, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiviral activity; Benzimidazoles; Carbamates; Synthesis

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CARBAMIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; COXSACKIE VIRUS B; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 2; NONHUMAN; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BENZIMIDAZOLES; CARBAMATES; CERCOPITHECUS AETHIOPS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; VERO CELLS;

EID: 0034018489     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00117-2     Document Type: Article

References (22)

1. O'Sullivan D.G., Wallis A.K. New benzimidazole derivatives with powerful protective action on tissue-culture cells infected with types 1,2, and 3 polio virus. Nature. 198:1963;1270-1273.
2. Porcari A.R., Devivar R.V., Kucera L.S., Drach J.C., Townsend L.B. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-((-d-ribofuranosyl)benzimidazole. J. Med. Chem. 41:1998;1252-1262.
3. Victor F., Brown T.J., Campanale K., Heinz B.A., Shirpley L.A., Su S.K., Tang J., Vance L.M., Spitzer W. Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime. J. Med. Chem. 40:1997;1511-1518.
4. Garuti L., Roberti M., Rossi T., Cermelli C., Portolani M., Malagoli M., Castelli M. Synthesis, antiviral and antiproliferative activity of some N-benzenesulphonyl-2-(2-or 3-pyridylethyl)-benzimidazoles. Anti-Cancer Drug Design. 13:1998;397-406.
5. Swayze E.E., Peiris S.M., Kucera L.S., White E.L., Wise D.S., Drach J.C., Townsend L.B. Synthesis of 1-(2-aminopropyl) benzimidazoles, structurally related to the TIBO derivative R82 with activity against human immunodeficiency virus. Bioorg. Med. Chem. Lett. 3:1993;543-546.
6. Gardiner J.M., Loyns C.R., Burke A., Khan A., Mahmood N. Synthesis and HIV-1 inhibition of novel benzimidazole derivatives. Bioorg. Med. Chem. Lett. 5:1995;1251-1254.
7. Klein J.P., Bender R., Kirsch R., Meichsner C., Paessens A., Rosner M., Rubsamen-Waigmann H., Kaiser R., Wichers M., Schneweis K.E., Winkler I., Reiss G. Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrob. Agents Chemother. 9:1995;2253-2257.
8. Font M., Monge A., Alvare E., Cuarter A., Losa M-J., Fidalgo M.-J., Sanmartin C., Sarobe P., Borras F. Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors, 1. Quinoline and quinoxaline derivatives. Drug Design and Discovery. 14:1997;305-332.
9. Ram S., Wise D.S., Wotring L.L., McCall J.W., Townsend L.B. Synthesis and biological activity of certain alkyl 5-(alkoxycarbonyl)-1H-benzimidazole-2-carbamates and related derivatives: a new class of potential antineoplastic and antifilarial agents. J. Med. Chem. 35:1992;539-547.
10. Dubey R., Abuzar S., Sharma S., Chatterjee R.K., Katiyar J.C. Synthesis and anthelmintic activity of 5(6)-(benzimidazol-2-ylcarbamoyl) and (4-substituted piperazin-1-yl) benzimidazoles. J. Med. Chem. 28:1985;1748-1750.
11. Williams T.M., Ciccarone T.M., MacToug S.C., Rooney C.S., Balani S.K., Condra J.H., Emini E.A., Goldman M.E., Greenlee W.J., Kauffman L.R., O'Brien J.A., Sardara V.V., Schleif W.A., Theoharides A.D., Anderson P.S. 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J. Med. Chem. 36:1993;1291-1294.
12. Artico M., Silvestri R., Massa S., Loi A.G., Corrias S., Piras G., La Colla P. 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones. J. Med. Chem. 39:1996;522-530.
13. Artico M. Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): a chemical survey from lead compounds to selected drugs for clinical trials. Il Farmaco. 51:1996;305-331.
14. Devivar R.V., Kawashima E., Revankar G.R., Breitenbach J.M., Kreske E.D., Drach J.C., Townsend L.B. Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)-and 2-(benzylthio)-5,6-dichloro-1-((-d-ribofuranosyl) benzimidazoles. J. Med. Chem. 37:1994;2942-2949.
15. Saluja S., Zou R., Drach J.C., Townsend L.B. Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy)methyl]- and-1-[(1,3-dihydroxy-2-propoxy)methyl] benzimidazoles. J. Med. Chem. 39:1996;881-891.
16. G. Holan, E.L. Samuel, 2-Trihalogenomethylbenzazoles. Part II. Reactions of 2-trihalogeno-methylbenzimidazoles with ammonia and amines, J. Chem. Soc. (C) (1967) 25-29.
17. B.C. Ennis, G. Holan, E.L. Samuel, 2-Trihalogenomethylbenzazoles. Part III. Reactions of 2-trichloro-methylbenzimidazole with nucleophiles, J. Chem. Soc. (C) (1967) 30-33.
18. Bednyagina N.P., Postovskil I.Y. Synthesis and hydrolytic decomposition of alkyl and benzyl sulfones of benzimidazole. Chem. Abstr. 54:1960;510c.
19. Haugwitz, D. Rudiger, Narayanan, L. Venkatachala, 2-(Alkylsulfonylmethyl) benzimidazole derivatives, Chem. Abstr. 76 (1972) 140820m.
20. Pavic I., Haltmann A., Zimmermann A., Michel D., Hampl W., Schleyer I., Mertens T. Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrob. Agents Chemother. 41:1997;2686-2692.
21. Shigeta S., Mori S., Watanabe J., Soeda S., Takahashi K., Yamase T. Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo. Antimicrob. Agents and Chemother. 41:1997;1423-1427.
22. Andrei G., Snoeck R., Vandeputte M., De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob. Agents and Chemother. 41:1997;587-593.